You just clicked a link to go to another website. If you continue, you may go to a site run by someone else.
We do not review or control the content on non-Medtronic sites, and we are not responsible for any business dealings or transactions you have there. Your use of the other site is subject to the terms of use and privacy statement on that site.
It is possible that some of the products on the other site are not approved in your region or country.
Your browser is out of date
With an updated browser, you will have a better Medtronic website experience. Update my browser now.
The content of this website is exclusively reserved for Healthcare Professionals in countries with applicable health authority product registrations.
Click “OK” to confirm you are a Healthcare Professional.
AIS Revascularisation Products
Methinks AI is a pioneering company in the development of artificial intelligence software for the early diagnosis of stroke. It is the first CE-marked medical device capable of detecting large vessel occlusions, both hyperdense and non-hyperdense, as well as intracerebral hemorrhages using non-contrast computed tomography. This technology helps optimize stroke patient triage and reduce time to treatment, significantly improving clinical outcomes.
Medtronic is proud to partner with Methinks AI to enhance stroke care across Central and Eastern Europe, Africa, Türkiye, Middle East. By leveraging Methinks AI-powered stroke detection software on Microsoft Teams base, we are accelerating early diagnosis and optimizing patient pathways as every second counts.